Untitled - Roche Trasplantes

DIAGNÓSTICO PRECOZ DEL RECHAZO SUBCLÍNICO MEDIANTE BIOPSIAS
DE PROTOCOLO
3. Matas AJ, Sibley R, Mauer SM y cols. Pre-discharge, post-transplant kidney biopsies
does not predict rejection. J Surg Res 1982; 32: 269-74.
4. Burdick JF, Beschorner WE, Smith WJ y cols. Characteristics of early routine renal
allograft biopsies. Transplantation 1984; 38: 679-83.
5. Solez K, Axelsen RA, Benediktsson H y cols. International standardization of criteria
for the histologic diagnosis of renal allograft rejection: The Banff working classification
of kidney transplant pathology. Kidney Int 1993; 44: 411-22.
6. Racusen LC, Solez K, Colvin RB y cols. The Banff 97 working classification of renal
allograft pathology. Kidney Int 1999; 55: 713-23.
7. Racusen LC, Colvin RB, Solez K y cols. Antibody-mediated rejection criteria-an addition
to the Banff’s 97 classification of renal allograft pathology. Am J Transplant 2003;
3: 708-14.
8. Furness PN, Philpott CM, Chorbadjian MT y cols. Protocol biopsy of the stable renal
transplant: a multicenter study of methods and complication rates. Transplantation
2003; 76: 969-73.
9. Schwarz A, Gwinner W, Hiss M, Radermacher J, Mengel M, Haller H. Safety and adequacy
of renal transplant protocol biopsies. Am J Transplant 2005; 5: 1992-6.
10. Grimm PC, Mckenna R, Nickerson P y cols. Clinical rejection is distinguished from
subclinical rejection by increased infiltration by a population of activated macrophages.
J Am Soc Nephrol 1999; 10: 1582-9.
11. Lipman M, Shen Y, Jeffery J y cols. Immune activation gene expression in stable renal
allograft biopsies: molecular evidence for subclinical rejection. Transplantation
1998; 66: 1673-81.
12. Rowshani AT, Florquin S, Bemelman F, Kummer JA, Hack CE, Ten Berge IJM.
Hyperexpression of the granzyme B inhibitor PI-9 in human renal allografts: A potential
mechanism for stable renal function in patients with subclinical rejection. Kidney
Int 2004; 66: 1417-22.
13. Veronese FV, Noronha IL, Manfro RC, Edelweiss MI, Goldberg J, Gonçalves LF.
Prevalence and immunohistochemichal findings of subclinical kidney allograft rejection
and its association with graft outcome. Clin Transplant 2004; 18: 357-64.
14. Sarwal M, Chua MS, Kambham N y cols. Molecular heterogeneity in acute renal allograft
rejection identified by DNA microarray profiling. N Eng J Med 2003; 349: 125-38.
15. Li B, Hartono C, Ding R y cols. Non invasive diagnosis of renal allograft rejection by
measurement of messenger RNA for perforine and granzyme B in urine. N Eng J Med
2001; 344: 947-54.
16. Muthukumar T, Dadhania D, Ding R y cols. Messenger RNA for FOXP3 in the urine
of renal-allograft recipients. N Eng J Med 2005; 353: 2342-51.
17. Schaub S, Rush D, Wilkins J y cols. Proteomic-based detection of urine proteins associated
with renal allograft rejection. J Am Soc Nephrol 2004; 15: 219-27.
18. Wittke S, Haubitz M, Walden M y cols. Detection of acute tubulointerstitial rejection
by proteomic analysis of urinary samples in renal transplant rejection. Am J Transplant
5; 2479-88.
47